Failure to detect complement-mediated antibody-dependent cytotoxicity against human orbital tissue cells in the serum of patients with thyroid-associated ophthalmopathy.
Antibodies which are cytotoxic to human eye muscle cells and orbital fibroblasts in antibody dependent cell-mediated cytotoxicity (ADCC) are routinely detected in the serum of patients with thyroid-associated ophthalmopathy (TAO). In the present study sera from patients with TAO, most of which were shown to be positive in ADCC against eye muscle cell targets, were tested for complement-mediated antibody-dependent cytotoxicity (CMAC) against human and pig eye muscle cells, human (abdominal) skeletal muscle cells and human orbital fibroblasts, in 51Cr release assays. Several different assay protocols and complement sources were used and patient and age, sex matched normal sera compared. In preliminary studies tests were always negative when eye muscle cells, other skeletal muscle cells, or orbital fibroblasts were used as targets, regardless of the complement source, or concentration, or assay conditions used. When larger numbers of patients and normals were tested in a single assay mean (+/- SE) % specific lysis for patients with TAO was not significantly different from that for normals for either eye muscle cells or other skeletal muscle cells and taking the upper limit of normal as mean + 2 SD for the normals, tests were positive in no patient with either target. On the other hand ADCC tests were positive in 57% of the same sera tested with the same eye muscle cell targets. When human thyroid cells were used as targets, tests were positive in 10 of the 14 patients tested and monoclonal antibodies, in enzyme-linked immunosorbent assay, reactive with eye muscle antigens gave positive lysis of eye muscle cells.2+ t
Dillon
J
J
Thyroid Research Unit, McGill University, Montreal General Hospital, Quebec, Canada.
Zhang
Z G
ZG
Hiromatsu
N
N
Bernard
M
M
Salvi
M
M
Wall
J R
JR
D000328:Adult; D000368:Aged; D000818:Animals; D000920:Antibody-Dependent Cell Cytotoxicity; D001323:Autoantibodies / Q000276:immunology*; D001327:Autoimmune Diseases / Q000276:immunology*; D002478:Cells, Cultured; D003167:Complement Activation; D003165:Complement System Proteins / Q000276:immunology*; D005128:Eye Diseases / Q000209:etiology / Q000276:immunology*; D005260:Female; D005347:Fibroblasts / Q000276:immunology; D006111:Graves Disease / Q000150:complications / Q000276:immunology*; D006168:Guinea Pigs; D006801:Humans; D008297:Male; D008875:Middle Aged; D009132:Muscles / Q000276:immunology; D009801:Oculomotor Muscles / Q000276:immunology; D009915:Orbit / Q000276:immunology*; D009928:Organ Specificity; D011817:Rabbits; D013552:Swine / Q000276:immunology
D001323:Autoantibodies; D003165:Complement System Proteins